Earnings Call · Q3 FY2021·2021-02-23

Q3 21EPS +12.17%·Rev n/aQ2 21EPS +27.50%·Rev n/aQ1 21EPS +100.00%*·Rev n/aQ4 20EPS -22.67%·Rev n/a⚠ consensus missing

Medtronic plc MDT

Ryan Weispfenning — Vice President and Head of Investor Relations

Geoffrey Martha — Chairman and Chief Executive Officer

Karen Parkhill — Chief Financial Officer

+1.9%1d on move date3d+1.8%5d+1.8%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MDT calls or request research access.

More MDT calls Browse calls Request research access